Correlation Between Protagonist Therapeutics and Mural Oncology

Can any of the company-specific risk be diversified away by investing in both Protagonist Therapeutics and Mural Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagonist Therapeutics and Mural Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Protagonist Therapeutics and Mural Oncology plc, you can compare the effects of market volatilities on Protagonist Therapeutics and Mural Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagonist Therapeutics with a short position of Mural Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagonist Therapeutics and Mural Oncology.

Diversification Opportunities for Protagonist Therapeutics and Mural Oncology

-0.28

Correlation Coefficient

Protagonist Therapeutics  Mural Oncology

Very good diversification

The 3 months correlation between Protagonist and Mural is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Protagonist Therapeutics and Mural Oncology plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mural Oncology plc and Protagonist Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagonist Therapeutics are associated (or correlated) with Mural Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mural Oncology plc has no effect on the direction of Protagonist Therapeutics i.e., Protagonist Therapeutics and Mural Oncology go up and down completely randomly.

Pair Corralation between Protagonist Therapeutics and Mural Oncology

Given the investment horizon of 90 days Protagonist Therapeutics is expected to generate 0.95 times more return on investment than Mural Oncology. However, Protagonist Therapeutics is 1.06 times less risky than Mural Oncology. It trades about 0.09 of its potential returns per unit of risk. Mural Oncology plc is currently generating about 0.01 per unit of risk. If you would invest  1,033  in Protagonist Therapeutics on September 18, 2024 and sell it today you would earn a total of  3,113  from holding Protagonist Therapeutics or generate 301.36% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	54.95%
Values	Daily Returns

Protagonist Therapeutics  vs.  Mural Oncology plc

Protagonist Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Protagonist Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong technical and fundamental indicators, Protagonist Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Mural Oncology plc

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Mural Oncology plc are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Mural Oncology is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Protagonist Therapeutics and Mural Oncology

The main advantage of trading using opposite Protagonist Therapeutics and Mural Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagonist Therapeutics position performs unexpectedly, Mural Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mural Oncology will offset losses from the drop in Mural Oncology's long position.

The idea behind Protagonist Therapeutics and Mural Oncology plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.